CompletedNot Applicable

Psychiatric Nurse-Delivered Eye Movement Desensitization and Reprocessing (EMDR) for Adults With Post-Traumatic Stress Symptoms in Jordan

Jordan70 participantsStarted 2023-03-15

Plain-language summary

Here is a plain-language, registry-appropriate Brief Summary you can paste into the form. It is written for patients, families, and healthcare providers: Brief Summary This study examines whether Eye Movement Desensitization and Reprocessing (EMDR) therapy can reduce the severity of symptoms in adults experiencing post-traumatic stress disorder (PTSD) in Jordan. PTSD can develop after exposure to distressing or traumatic life events and may cause symptoms such as intrusive memories, avoidance, sleep problems, anxiety, and emotional distress. A total of 70 adult participants with moderate to severe PTSD symptoms were enrolled. Participants were assigned to one of two groups: an EMDR therapy group or a waitlist control group. Individuals in the EMDR group received structured therapy sessions delivered by a trained mental-health professional, while those in the waitlist group did not receive therapy during the study period but were offered treatment after the study ended. PTSD symptom severity was measured before treatment, immediately after the therapy sessions, and again one month later. The goal of the study was to determine whether EMDR therapy leads to meaningful and lasting reductions in PTSD symptoms compared with no immediate treatment. The findings of this research are intended to help healthcare providers and policymakers understand the value of EMDR as a non-pharmacological, evidence-based treatment option for individuals experiencing trauma-related distress, and to support improvements in mental-health services and trauma-informed care in Jordan.

Who can participate

Age range

18 Years

Sex

ALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: Adults aged 18 years or older Probable PTSD or moderate-to-severe post-traumatic stress symptoms based on the screening instrument used in the study Exposure to at least one traumatic or highly stressful life event within the previous six months No prior receipt of EMDR therapy Willingness and ability to provide informed consent and participate in therapy sessions and assessments Exclusion Criteria: Acute cognitive or intellectual disability that would interfere with comprehension of study procedures or questionnaires Significant visual impairment or visual pathology that would prevent full engagement with the visual components of EMDR therapy Inability to communicate effectively by phone for scheduled assessments Refusal or inability to provide informed consent

Questions worth asking your doctor

Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.

1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?

Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.

Questions for the trial coordinator

The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.

1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?

A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.

What they're measuring

Severity of post-traumatic stress symptoms

Timeframe: Baseline, immediately after intervention, and 1-month follow-up.

Trial details

NCT IDNCT07423832

SponsorAl-Quds University

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2023-12-25

View on ClinicalTrials.gov More PTSD - Post Traumatic Stress Disorder trials